Onychomatricoma: Difference between revisions

From WikiMD's Wellness Encyclopedia

No edit summary
Tag: Manual revert
CSV import
 
Line 1: Line 1:
{{Infobox medical condition
| name            = Onychomatricoma
| synonyms        =
| specialty      = [[Dermatology]]
| symptoms        = Thickened [[nail]], [[nail plate]] discoloration, [[splinter hemorrhages]]
| complications  =
| onset          =
| duration        =
| causes          = Unknown
| risks          =
| diagnosis      = [[Clinical examination]], [[dermoscopy]], [[histopathology]]
| differential    = [[Onychomycosis]], [[glomus tumor]], [[subungual exostosis]]
| treatment      = [[Surgical excision]]
| medication      =
| prognosis      = Excellent with complete excision
| frequency      = Rare
}}
'''Onychomatricoma''' is a rare benign [[tumor]] of the [[nail matrix]] that was first described in 1992 by Baran and Kint. It is characterized by a slow-growing, painless, thickened nail plate with splinter hemorrhages and xanthonychia. The tumor is often misdiagnosed due to its rarity and lack of awareness among clinicians.
'''Onychomatricoma''' is a rare benign [[tumor]] of the [[nail matrix]] that was first described in 1992 by Baran and Kint. It is characterized by a slow-growing, painless, thickened nail plate with splinter hemorrhages and xanthonychia. The tumor is often misdiagnosed due to its rarity and lack of awareness among clinicians.
== Clinical Presentation ==
== Clinical Presentation ==
Patients with onychomatricoma typically present with a slow-growing, thickened nail plate that may be associated with pain. The nail plate often shows longitudinal ridging and splitting, with splinter hemorrhages and xanthonychia. The nail may also be deformed or partially destroyed.
Patients with onychomatricoma typically present with a slow-growing, thickened nail plate that may be associated with pain. The nail plate often shows longitudinal ridging and splitting, with splinter hemorrhages and xanthonychia. The nail may also be deformed or partially destroyed.
== Diagnosis ==
== Diagnosis ==
The diagnosis of onychomatricoma is often challenging due to its rarity and the lack of specific clinical features. The diagnosis is usually confirmed by [[histopathology]] following a nail biopsy. Histologically, the tumor is characterized by the presence of fibroepithelial papillae and a thickened nail matrix.
The diagnosis of onychomatricoma is often challenging due to its rarity and the lack of specific clinical features. The diagnosis is usually confirmed by [[histopathology]] following a nail biopsy. Histologically, the tumor is characterized by the presence of fibroepithelial papillae and a thickened nail matrix.
== Treatment ==
== Treatment ==
The treatment of choice for onychomatricoma is complete surgical excision of the tumor. This usually results in a cure, although recurrence has been reported in some cases.
The treatment of choice for onychomatricoma is complete surgical excision of the tumor. This usually results in a cure, although recurrence has been reported in some cases.
== Prognosis ==
== Prognosis ==
The prognosis for patients with onychomatricoma is generally good, as the tumor is benign and does not metastasize. However, the tumor can cause significant morbidity due to its effects on the nail and the potential for recurrence.
The prognosis for patients with onychomatricoma is generally good, as the tumor is benign and does not metastasize. However, the tumor can cause significant morbidity due to its effects on the nail and the potential for recurrence.
== See Also ==
== See Also ==
* [[Nail Diseases]]
* [[Nail Diseases]]
* [[Nail Tumors]]
* [[Nail Tumors]]
* [[Benign Tumors]]
* [[Benign Tumors]]
== References ==
== References ==
* Baran R, Kint A. Onychomatricoma. J Am Acad Dermatol. 1992;26(2 Pt 1):247-250.
* Baran R, Kint A. Onychomatricoma. J Am Acad Dermatol. 1992;26(2 Pt 1):247-250.
* Perrin C, Baran R, Pisani A, et al. The onychomatricoma: additional histologic criteria and immunohistochemical study. Am J Dermatopathol. 2002;24(3):199-203.
* Perrin C, Baran R, Pisani A, et al. The onychomatricoma: additional histologic criteria and immunohistochemical study. Am J Dermatopathol. 2002;24(3):199-203.
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Skin Conditions]]
[[Category:Skin Conditions]]
[[Category:Nail Diseases]]
[[Category:Nail Diseases]]
[[Category:Tumors]]
[[Category:Tumors]]
{{stub}}
{{stub}}
{{No image}}
{{No image}}

Latest revision as of 04:33, 4 April 2025


Onychomatricoma
Synonyms
Pronounce N/A
Specialty Dermatology
Symptoms Thickened nail, nail plate discoloration, splinter hemorrhages
Complications
Onset
Duration
Types N/A
Causes Unknown
Risks
Diagnosis Clinical examination, dermoscopy, histopathology
Differential diagnosis Onychomycosis, glomus tumor, subungual exostosis
Prevention N/A
Treatment Surgical excision
Medication
Prognosis Excellent with complete excision
Frequency Rare
Deaths N/A


Onychomatricoma is a rare benign tumor of the nail matrix that was first described in 1992 by Baran and Kint. It is characterized by a slow-growing, painless, thickened nail plate with splinter hemorrhages and xanthonychia. The tumor is often misdiagnosed due to its rarity and lack of awareness among clinicians.

Clinical Presentation[edit]

Patients with onychomatricoma typically present with a slow-growing, thickened nail plate that may be associated with pain. The nail plate often shows longitudinal ridging and splitting, with splinter hemorrhages and xanthonychia. The nail may also be deformed or partially destroyed.

Diagnosis[edit]

The diagnosis of onychomatricoma is often challenging due to its rarity and the lack of specific clinical features. The diagnosis is usually confirmed by histopathology following a nail biopsy. Histologically, the tumor is characterized by the presence of fibroepithelial papillae and a thickened nail matrix.

Treatment[edit]

The treatment of choice for onychomatricoma is complete surgical excision of the tumor. This usually results in a cure, although recurrence has been reported in some cases.

Prognosis[edit]

The prognosis for patients with onychomatricoma is generally good, as the tumor is benign and does not metastasize. However, the tumor can cause significant morbidity due to its effects on the nail and the potential for recurrence.

See Also[edit]

References[edit]

  • Baran R, Kint A. Onychomatricoma. J Am Acad Dermatol. 1992;26(2 Pt 1):247-250.
  • Perrin C, Baran R, Pisani A, et al. The onychomatricoma: additional histologic criteria and immunohistochemical study. Am J Dermatopathol. 2002;24(3):199-203.
This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia